Search

Supplemental material, sj-pdf-1-eso-10.1177_2396987320975736 for Clinical usefulness of Edinburgh CT criteria in patients with lobar intracerebral hemorrhage by Raffaele Ornello, Enrico Colangeli, Emanuele Tommasino, Cindy Tiseo, Giulia Perrotta, Ciro Scarpato, Martina Gentile, Leondino Mammarella, Carmine Marini, Francesca Pistoia, Alessandra Splendiani and Simona Sacco in European Stroke Journal

Supplemental material, sj-pdf-1-eso-10.1177_2396987320975736 for Clinical usefulness of Edinburgh CT criteria in patients with lobar intracerebral hemorrhage by Raffaele Ornello, Enrico Colangeli, Emanuele Tommasino, Cindy Tiseo, Giulia Perrotta, Ciro Scarpato, Martina Gentile, Leondino Mammarella, Carmine Marini, Francesca Pistoia, Alessandra Splendiani and Simona Sacco in European Stroke Journal

Simple Summary Magnetic Resonance Imaging (MRI) is a consolidated imaging tool for the multiparametric assessment of tissues in various pathologies from degenerative and inflammatory diseases to cancer. In recent years, the continuous technological evolution of the equipment has led to the development of sequences that provide not only anatomical but also functional and metabolic information. In addition, there is a growing and emerging field of research in clinical applications using MRI to exploit the diagnostic and therapeutic capabilities of nanocompounds. This review illustrates the application of the most advanced magnetic resonance techniques in the field of nanomedicine. In the last decades, nanotechnology has been used in a wide range of biomedical applications, both diagnostic and therapeutic. In this scenario, imaging techniques represent a fundamental tool to obtain information about the properties of nanoconstructs and their interactions with the biological environment in preclinical and clinical settings. This paper reviews the state of the art of the application of magnetic resonance imaging in the field of nanomedicine, as well as the use of nanoparticles as diagnostic and therapeutic tools, especially in cancer, including the characteristics that hinder the use of nanoparticles in clinical practice.